Prostate News Archive
09-Oct-2008
Prostate Meds Not Tied to Increased Hip Fracture Risk (HealthDay via Yahoo! News)
TUESDAY, Oct. 7 (HealthDay News) -- A new study found no link between the use of a drug to treat an enlarged prostate and an increase in hip fractures in men. BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine (Medical News Today)
BN ImmunoTherapeutics has now evaluated the mature Phase II data from the therapeutic prostate cancer vaccine candidate PROSTVAC(TM) that had been obtained as part of the recently entered partnership with the National Cancer Institute (NCI) in the US. New risk factor for prostate cancer (PhysOrg)
(PhysOrg.com) -- The greater the levels of a protein called Insulin-like Growth Factor-1 (IGF-1), the greater the risk of prostate cancer, an Oxford University-led study has found. The results are published in the journal Annals of Internal Medicine. Researchers Unravel New Aspects Of The Male Hormone (Androgen) Receptor Regulation In Prostate Cancer (Medical News Today)
A team of researchers in the Center for prostate Disease Research (CPDR) at the Uniformed Services University of the Health Sciences (USU), led by Dr. Shiv Srivastava, professor of surgery, are working to define male hormone regulated transcriptome in prostate cancer cells.
Back to Prostate News Archive
